The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy

被引：4

作者：

Califf, RM

Stump, D

Topol, EJ

Mark, DB

机构：

[1] Duke Clin Res Inst, Durham, NC 27715 USA

[2] Genentech Inc, San Francisco, CA 94080 USA

[3] Cleveland Clin Fdn, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Cardiol, Cleveland, OH USA

来源：

AMERICAN HEART JOURNAL | 1999年 / 137卷 / 05期

关键词：

D O I：

10.1016/S0002-8703(99)70438-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S90 / S93

页数：4

共 16 条

[1]

*AIMS TRIAL STUD G, 1988, LANCET, V2, P545

[2]

[Anonymous], 1988, LANCET, V2, P349

[3]

[Anonymous], 1986, LANCET, V1, P397

[4] One-year results from the global utilization of streptokinase and TPA for occluded coronary arteries (GUSTO-I) trial [J].

Califf, RM ;

White, HD ;

VandeWerf, EV ;

Sadowski, Z ;

Armstrong, PW ;

Vahanian, A ;

Simoons, ML ;

Simes, RJ ;

Lee, KL ;

Topol, EJ .

CIRCULATION, 1996, 94 (06) :1233-1238

[5] FROM MYOCARDIAL SALVAGE TO PATIENT SALVAGE IN ACUTE MYOCARDIAL-INFARCTION - THE ROLE OF REPERFUSION THERAPY [J].

CALIFF, RM ;

TOPOL, EJ ;

GERSH, BJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (05) :1382-1388

[6] RANDOMIZED ANGIOGRAPHIC TRIAL OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (ALTEPLASE) IN MYOCARDIAL-INFARCTION [J].

CARNEY, RJ ;

MURPHY, GA ;

BRANDT, TR ;

DALEY, PJ ;

PICKERING, E ;

WHITE, HJ ;

MCDONOUGH, TJ ;

VERMILYA, SK ;

TEICHMAN, SL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (01) :17-23

[7]

*ISIS 3, 1993, LANCET, V339, P753

[8]

LINCOFF AM, 1993, CIRCULATION, V87, P1792

[9] COST-EFFECTIVENESS OF THROMBOLYTIC THERAPY WITH TISSUE-PLASMINOGEN ACTIVATOR AS COMPARED WITH STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION [J].

MARK, DB ;

HLATKY, MA ;

CALIFF, RM ;

NAYLOR, CD ;

LEE, KL ;

ARMSTRONG, PW ;

BARBASH, G ;

WHITE, H ;

SIMOONS, ML ;

NELSON, CL ;

CLAPPCHANNING, N ;

KNIGHT, JD ;

HARRELL, FE ;

SIMES, J ;

TOPOL, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21) :1418-1424

[10] IMPROVED THROMBOLYSIS WITH A MODIFIED DOSE REGIMEN OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].

NEUHAUS, KL ;

FEUERER, W ;

JEEPTEBBE, S ;

NIEDERER, W ;

VOGT, A ;

TEBBE, U .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (06) :1566-1569

← 1 2 →